1 funding article on VCXpress · latest round: Series A
Beijing-based BioGeometry closes Series A+ extension with $100 million funding led by China Life Capital, accelerating development of AI models GeoFlow and GeoCell for de novo drug design and cell-level prediction.
Series A · $100 million